Celanese (CE) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
17 Dec, 2025Executive summary
Leadership is prioritizing cash generation, productivity, and cost reduction to drive shareholder value, with decisive actions taken in the first two months of the new CEO's tenure.
Global chemical and specialty materials company with $10.3B in 2024 net sales and $2.4B operating EBITDA, operating in 20+ countries with 56 manufacturing sites and over 12,000 employees.
Cost reduction actions exceeded $75 million target for 2025, including SG&A cuts and closure of the Luxembourg Mylar Specialty Films JV.
Aggressive focus on deleveraging, portfolio review, and operational improvements to restore top-tier industry performance.
Leadership changes included Scott Richardson appointed CEO and several new board members.
Financial highlights
2024 net sales reached $10.3B; operating EBITDA was $2.4B; adjusted EBIT was $1.6B; free cash flow was $498M; $307M returned to shareholders; $1.0B in bonds retired.
Adjusted EPS grew at a 13% CAGR from 2012 to 2024, reaching $15.88 in 2023 and $11.00 in 2024.
Q1 2025 EBITDA guidance is around $400M, with expectations for improvement in the second half of the year through cost and productivity actions.
$250M of synergies achieved from the M&M acquisition, with further cost and productivity gains targeted.
CapEx spend reduced from $568M in 2023 to $435M in 2024, with a 2025 target of $300–$350M.
Outlook and guidance
No full-year 2025 earnings guidance provided, but management expects EBITDA to be higher in the second half versus the first half, driven by complexity reduction, margin recovery, and leveraging the Acetyls optionality model.
Q1 2025 EPS guidance of $0.25–$0.50, with Q2 expected to improve by ~$1.00 per share sequentially.
Focus remains on executing cost actions, driving smaller, quickly commercializable projects, and expanding the Engineered Materials pipeline.
Management is not considering an equity raise due to the strength of the debt market and is prioritizing debt-funded acquisitions and divestitures for deleveraging.
Demand and pricing challenges expected to persist into Q1 2025, with additional headwinds from seasonality and a planned outage at Bishop, Texas.
Latest events from Celanese
- Board refreshment, pay-for-performance, and ESG oversight highlight this year's proxy.CE
Proxy Filing4 Mar 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, all board-backed.CE
Proxy Filing4 Mar 2026 - 2026 targets $650M–$750M free cash flow after strong 2025 cash generation and cost cuts.CE
Q4 202518 Feb 2026 - Q1 2025 net loss, cost cuts, and refinancing support $700–$800M free cash flow target.CE
Q1 20253 Feb 2026 - Q2 2024 delivered record Engineered Materials results and resilient earnings amid supply headwinds.CE
Q2 20242 Feb 2026 - Q3 profit drop, 95% dividend cut, and cost actions target deleveraging amid weak demand.CE
Q3 202416 Jan 2026 - Shareholders to vote on board refreshment, governance reforms, and executive pay amid strategic transformation.CE
Proxy Filing1 Dec 2025 - Board refreshment, governance reforms, and ESG integration drive strategic transformation.CE
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, auditor, compensation, and key governance changes.CE
Proxy Filing1 Dec 2025